The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during 2024–2032.

Highlights $3M in funding from NRCan's Energy Innovation Program. Funds ongoing development, process optimization and scaled-up production of LFP cathode materials utilizing a range of iron input ...

In 2026, the competitive edge isn't where your data sits, but how fast it moves. We compare how the top five platforms are ...

Nektony, a leading developer of macOS utility software, today announced a landmark update to its flagship product, App ...

The prospects for AI to sustain build-out spending and to harm legacy industries continue to be front of mind for Wall Street ...

The prospects for AI to sustain build-out spending and to harm legacy industries continue to be front of mind for Wall Street ...